Provention Bio, Inc. / Fundamentals
Income statement
- Net revenue
€11.13M - Cost of goods sold
€441.87K - Gross profit
€10.69M - SG&A expenses
€55.33M - R&D expenses
€65.42M - EBITDA
-€107.79M - D&A
€2.82M - EBIT
-€110.61M - Interest expenses
€1.02M - EBT
-€109.57M - Tax expenses
-€12.07M - Net income
-€97.50M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€31.07K - Changes in working capital
€15.48M - Operating cash flow
-€65.08M - Capex
€686.11K - Other investing cash flow
-€12.95M - Net investing cash flow
-€76.06M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€111.66M - Net financing cash flow
€111.66M - Foreign exchange effects
€0.00 - Net change in cash
-€29.47M - Cash at end of period
€38.01M - Free cash flow
-€64.39M
Balance sheet
- Cash and cash equivalents
€38.01M - Cash and short-term investments
€142.40M - Total receivables
€1.17M - Inventory
€1.06M - Other current assets
€6.09M - Total current assets
€150.73M - Property, plant & equipment
€2.18M - Goodwill
€0.00 - Intangible assets
€51.40M - Long-term investments
€0.00 - Other non-current assets
€103.56K - Total non-current assets
€53.69M - Total assets
€204.42M - Accounts payable
€5.83M - Short-term debt
€0.00 - Other current liabilities
€56.91M - Total current liabilities
€78.01M - Long-term debt
€20.64M - Deferred tax liabilities
-€20.26M - Other non-current liabilities
€0.00 - Total non-current liabilities
€21.25M - Total liabilities
€99.26M - Common stock
€7.77K - Retained earnings
-€350.08M - Other equity
-€558.38K - Total equity
€105.16M - Total liabilities and shareholders' equity
€204.42M
Company information
- Market capitalization
€2.03B - Employees
174 - Enterprise Value
€2.36B
Company ratios
- Gross margin
-
96.0% Much better than peer group: -14,955.0% - EBITDA margin
-
-968.6% Much better than peer group: -36,674.4% - EBIT margin
-
-993.9% Much better than peer group: -36,376.6% - EBT margin
-
-984.5% Much better than peer group: -38,809.2% - Net margin
-
-876.1% Much better than peer group: -37,979.7% - ROE
-
-92.7% Worse than peer group: -87.2% - ROA
-
-47.7% Even with peer group: -51.5% - Asset turnover
-
5.4% Worse than peer group: 13.7% - FCF margin
-
-590.9% Much better than peer group: -30,746.7% - FCF yield
-3.2% - Efficiency ratio
1,068.6% - Net sales per employee
-
€63.96K - Net income per employee
-
-€560.35K